Heterologous expression, purification and characterization of the influenza A virus M2e gene fused to Mycobacterium tuberculosis HSP70359-610 in prokaryotic system as a fusion protein

Molecular Biology Reports

Volumn 37, Issue 6, 2010, Pages 2877-2883

  Ebrahimi, Seyyed Mahmoud ^a   Tebianian, Majid ^a  

^a RAZI VACCINE AND SERUM RESEARCH INSTITUTE   (Iran)

Author keywords

HSP70; Immunity; Influenza A virus; M2e; Protection; Vaccine

Indexed keywords

HYBRID PROTEIN; IMMUNOLOGICAL ADJUVANT; PROTEIN M2 HEAT SHOCK FUSION PROTEIN 70; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; UREA; HEAT SHOCK PROTEIN 70; VIRUS PROTEIN;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ANTIGENICITY; ARTICLE; BIOLOGICAL ACTIVITY; CARBOXY TERMINAL SEQUENCE; CELL STRAIN; CONTROLLED STUDY; DNA PURIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; EXPRESSION VECTOR; GENE FUSION; GENE OVEREXPRESSION; HETEROLOGOUS EXPRESSION; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOREACTIVITY; INFLUENZA VIRUS A; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROKARYOTE; PROTEIN ANALYSIS; PROTEIN DENATURATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; QUALITATIVE ANALYSIS; RABBIT; VIRUS MUTATION; WESTERN BLOTTING; ANIMAL; CELL LINE; DOG; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; PROKARYOTIC CELL; VIRUS GENE;

ANIMALS; BLOTTING, WESTERN; CELL LINE; DOGS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENES, VIRAL; HSP70 HEAT-SHOCK PROTEINS; INFLUENZA A VIRUS; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; PROKARYOTIC CELLS; RECOMBINANT FUSION PROTEINS; VIRAL PROTEINS;

ANIMALIA; ESCHERICHIA COLI; INFLUENZA A VIRUS; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS C; ORTHOMYXOVIRIDAE; ORYCTOLAGUS CUNICULUS; PROKARYOTA;

EID: 77955664767     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-009-9846-2     Document Type: Article

References (19)

1. SM Ebrahimi K Aghaiypour H Nili 2008 Sequence analysis of M2 gene of avian influenza virus strain (A/Chicken/Iran/101/98 (H9N2)) as an oil vaccine seed Iran J Biotechnol 6 229 232
2. RA Lamb SL Zebedee CD Richardson 1985 Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface Cell 40 627 633 10.1016/0092-8674(85)90211-9 1:CAS:528:DyaL2MXitVSku70%3D 3882238
3. LJ Holsinger RA Lamb 1991 Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds Virology 183 32 43 10.1016/0042-6822(91)90115-R 1:CAS:528:DyaK3MXksVCmtL8%3D 2053285
4. LH Pinto LJ Holsinger RA Lamb 1992 Influenza virus M2 protein has ion channel activity Cell 69 517 528 10.1016/0092-8674(92)90452-I 1:CAS:528:DyaK38Xks1Cqtrg%3D 1374685
5. RA Black PA Rota N Gorodkova HD Klenk AP Kendal 1993 Antibody response to the M2 protein of influenza A virus expressed in insect cells J Gen Virol 74 143 146 10.1099/0022-1317-74-1-143 1:CAS:528:DyaK3sXpvFyktQ%3D%3D 8423445
6. CF Hung WF Cheng CY Chai KF Hsu L He M Ling TC Wu 2001 Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen J Immunol 166 5733 5740 1:CAS:528:DC%2BD3MXjtFyqsr0%3D 11313416
7. MG Cusi C Terrosi GG Savellini G Di Genova R Zurbriggen P Correale 2004 Efficient delivery of DNA to dendritic cells mediated by influenza virosomes Vaccine 22 735 739 10.1016/j.vaccine.2003.08.024 14741166 (Pubitemid 38114904)
8. SA Calarota DB Weiner 2004 Enhancement of human immunodeficiency virus type 1-DNA vaccine potency through incorporation of T-helper 1 molecular adjutants Immunol Rev 199 84 99 10.1111/j.0105-2896.2004.00150.x 1:CAS:528:DC%2BD2cXltFygsL4%3D 15233728 (Pubitemid 38736766)
9. KR Qazia M Wikmanb NM Vasconcelos K Berzins S Stahl C Fernández 2005 Enhancement of DNA vaccine potency by linkage of plasmodium falciparum malarial antigen gene fused with a fragment of HSP70 gene Vaccine 23 1114 1125 10.1016/j.vaccine.2004.08.033 (Pubitemid 40052008)
10. CH Chen TL Wang CF Hung Y Yang RA Young DM Pardoll 2000 Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene Cancer Res 60 1035 1042 1:CAS:528:DC%2BD3cXhs1ShsL0%3D 10706121
11. S Lindquist EA Craig 1988 The heat-shock proteins Annu Rev Genet 22 631 677 10.1146/annurev.ge.22.120188.003215 1:CAS:528:DyaL1MXhtlSmtbg%3D 2853609
12. T Lehner Y Wang T Whittall E McGowan CG Kelly M Singh 2004 Functional domains of HSP70 stimulate generation of cytokines and chemokines, maturation of dendritic cells and adjuvanticity Biochem Soc Trans 32 629 632 10.1042/BST0320629 1:CAS:528:DC%2BD2cXmtFGjtr8%3D 15270693 (Pubitemid 39120401)
13. T Becker FU Hartl F Wieland 2002 CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes J Cell Biol 158 1277 1285 10.1083/jcb.200208083 1:CAS:528:DC%2BD38Xns1equr0%3D 12356871
14. Y Wang CG Kelly JT Karttunen T Whittall PJ Lehner L Duncan 2001 LCD40 is a cellular receptor mediating mycobacterial heat shock protein 70 stimulation of CC-chemokines Immunity 15 971 983 10.1016/S1074-7613(01)00242-4 1:CAS:528:DC%2BD38Xhsl2ksw%3D%3D 11754818 (Pubitemid 34075377)
15. Y Wang CG Kelly M Singh EG McGowan AS Carrara LA Bergmeier T Lehner 2002 Stimulation of Th1-polarizing cytokines, C-C chemokines, maturation of dendritic cells, and adjuvant function by the peptide binding fragment of heat shock protein 70 J Immunol 169 2422 2429 1:CAS:528:DC%2BD38XmsF2gtbk%3D 12193710
16. X Li X Yang L Li H Liu J Liu 2006 A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine Vaccine 24 3321 3331 10.1016/j.vaccine.2006.01.012 1:CAS:528: DC%2BD28XivFSjs7k%3D 16472546
17. UK Laemmli 1970 Cleavage of structural proteins during assembly of the head of bacteriophage T4 Nature 277 680 685 10.1038/227680a0
18. RB Belshe MH Smith CB Hall R Betts AJ Hay 1988 Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection J Virol 62 1508 1512 1:CAS:528:DyaL1cXmtVGrsr4%3D 3282079
19. IA Leneva N Roberts EA Govorkova OG Goloubeva RG Webster 2000 The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses Antiviral Res 48 101 115 10.1016/S0166-3542(00)00123-6 1:CAS:528: DC%2BD3cXoslGht7g%3D 11114412